274 related articles for article (PubMed ID: 3297141)
1. Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu.
Swart GW; Parmeggiani A; Kraal B; Bosch L
Biochemistry; 1987 Apr; 26(7):2047-54. PubMed ID: 3297141
[TBL] [Abstract][Full Text] [Related]
2. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
Jacquet E; Parmeggiani A
Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
[TBL] [Abstract][Full Text] [Related]
3. Probing the reactivity of the GTP- and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A.
Anborgh PH; Parmeggiani A
J Biol Chem; 1993 Nov; 268(33):24622-8. PubMed ID: 8227020
[TBL] [Abstract][Full Text] [Related]
4. The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.
Vorstenbosch E; Pape T; Rodnina MV; Kraal B; Wintermeyer W
EMBO J; 1996 Dec; 15(23):6766-74. PubMed ID: 8978702
[TBL] [Abstract][Full Text] [Related]
5. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
Jensen M; Cool RH; Mortensen KK; Clark BF; Parmeggiani A
Eur J Biochem; 1989 Jun; 182(2):247-55. PubMed ID: 2661226
[TBL] [Abstract][Full Text] [Related]
7. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
8. Molecular properties of two mutant species of the elongation factor Tu.
Van der Meide PH; Duisterwinkel FJ; De Graaf JM; Kraal B; Bosch L; Douglass J; Blumenthal T
Eur J Biochem; 1981 Jun; 117(1):1-6. PubMed ID: 7021152
[TBL] [Abstract][Full Text] [Related]
9. The interaction between aminoacyl-tRNA and the mutant elongation factors Tu AR and B0.
Abrahams JP; Acampo JJ; Ott G; Sprinzl M; de Graaf JM; Talens A; Kraal B
Biochim Biophys Acta; 1990 Aug; 1050(1-3):226-9. PubMed ID: 2207147
[TBL] [Abstract][Full Text] [Related]
10. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
[TBL] [Abstract][Full Text] [Related]
11. A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycin.
Duisterwinkel FJ; De Graaf JM; Schretlen PJ; Kraal B; Bosch L
Eur J Biochem; 1981 Jun; 117(1):7-12. PubMed ID: 7021158
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome.
Tubulekas I; Hughes D
J Bacteriol; 1993 Jan; 175(1):240-50. PubMed ID: 8416899
[TBL] [Abstract][Full Text] [Related]
13. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
Fasano O; Parmeggiani A
Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
[TBL] [Abstract][Full Text] [Related]
14. The influence of different modifications of elongation factor Tu from Escherichia coli on ternary complex formation investigated by fluorescence spectroscopy.
Ott G; Jonák J; Abrahams IP; Sprinzl M
Nucleic Acids Res; 1990 Feb; 18(3):437-41. PubMed ID: 2408011
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence characterization of the interaction of various transfer RNA species with elongation factor Tu.GTP: evidence for a new functional role for elongation factor Tu in protein biosynthesis.
Janiak F; Dell VA; Abrahamson JK; Watson BS; Miller DL; Johnson AE
Biochemistry; 1990 May; 29(18):4268-77. PubMed ID: 2190631
[TBL] [Abstract][Full Text] [Related]
16. Structure-function relationships in the GTP binding domain of EF-Tu: mutation of Val20, the residue homologous to position 12 in p21.
Jacquet E; Parmeggiani A
EMBO J; 1988 Sep; 7(9):2861-7. PubMed ID: 3181143
[TBL] [Abstract][Full Text] [Related]
17. Effects of nucleotide- and aurodox-induced changes in elongation factor Tu conformation upon its interactions with aminoacyl transfer RNA. A fluorescence study.
Dell VA; Miller DL; Johnson AE
Biochemistry; 1990 Feb; 29(7):1757-63. PubMed ID: 2110000
[TBL] [Abstract][Full Text] [Related]
18. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
Wolf H; Chinali G; Parmeggiani A
Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
[TBL] [Abstract][Full Text] [Related]
19. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
Navratil T; Spremulli LL
Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
[TBL] [Abstract][Full Text] [Related]
20. Synergism between the GTPase activities of EF-Tu.GTP and EF-G.GTP on empty ribosomes. Elongation factors as stimulators of the ribosomal oscillation between two conformations.
Mesters JR; Potapov AP; de Graaf JM; Kraal B
J Mol Biol; 1994 Oct; 242(5):644-54. PubMed ID: 7932721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
